Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Plenge

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Rheumatic Diseases Clinics of North America|June 1, 2010
Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritisRobert M Plenge, Soumya Raychaudhuri
JAMA|August 11, 2011
Genomic technology applied to pharmacological traitsJun J Yang, Robert M Plenge
Arthritis and Rheumatism|March 2, 2011
Personalized medicine in rheumatoid arthritis: miles to go before we sleepRobert M Plenge, S Louis Bridges
Current Opinion in Rheumatology|March 20, 2008
Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directionsRobert M Plenge, Lindsey A Criswell
Current Opinion in Rheumatology|November 27, 2013
Genome-wide association studies to advance our understanding of critical cell types and pathways in rheumatoid arthritis: recent findings and challengesDorothée Diogo, Yukinori Okada, Robert M Plenge
Nature Reviews. Drug Discovery|July 23, 2013
Validating therapeutic targets through human geneticsRobert M Plenge, Edward M Scolnick, David Altshuler
Current Opinion in Immunology|October 3, 2012
GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disordersPeter K Gregersen, Betty Diamond, Robert M Plenge
Nature Reviews. Drug Discovery|June 5, 2024
Sequential immunotherapy: towards cures for autoimmunityFrancisco Ramírez-Valle, Joseph C Maranville, Sophie Roy, et al.
Nature Reviews. Drug Discovery|July 22, 2024
Author Correction: Sequential immunotherapy: towards cures for autoimmunityFrancisco Ramírez-Valle, Joseph C Maranville, Sophie Roy, et al.
Science (New York, N.Y.)|May 11, 2002
Autosomal dominant mutations affecting X inactivation choice in the mouseIvona Percec, Robert M Plenge, Joseph H Nadeau, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Rheumatic Diseases Clinics of North America|June 1, 2010
Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritisRobert M Plenge, Soumya Raychaudhuri
JAMA|August 11, 2011
Genomic technology applied to pharmacological traitsJun J Yang, Robert M Plenge
Arthritis and Rheumatism|March 2, 2011
Personalized medicine in rheumatoid arthritis: miles to go before we sleepRobert M Plenge, S Louis Bridges
Current Opinion in Rheumatology|March 20, 2008
Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directionsRobert M Plenge, Lindsey A Criswell
Current Opinion in Rheumatology|November 27, 2013
Genome-wide association studies to advance our understanding of critical cell types and pathways in rheumatoid arthritis: recent findings and challengesDorothée Diogo, Yukinori Okada, Robert M Plenge
Nature Reviews. Drug Discovery|July 23, 2013
Validating therapeutic targets through human geneticsRobert M Plenge, Edward M Scolnick, David Altshuler
Current Opinion in Immunology|October 3, 2012
GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disordersPeter K Gregersen, Betty Diamond, Robert M Plenge
Nature Reviews. Drug Discovery|June 5, 2024
Sequential immunotherapy: towards cures for autoimmunityFrancisco Ramírez-Valle, Joseph C Maranville, Sophie Roy, et al.
Nature Reviews. Drug Discovery|July 22, 2024
Author Correction: Sequential immunotherapy: towards cures for autoimmunityFrancisco Ramírez-Valle, Joseph C Maranville, Sophie Roy, et al.
Science (New York, N.Y.)|May 11, 2002
Autosomal dominant mutations affecting X inactivation choice in the mouseIvona Percec, Robert M Plenge, Joseph H Nadeau, et al.
Pageof 12